The New Solution uses SOPHiA DDM™ and aims to Benefit Cancer Research , Clinical Studies and Patient Care BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Feb. 28, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced that Synergy Oncology,
